Viewing Study NCT04493203


Ignite Creation Date: 2025-12-24 @ 7:17 PM
Ignite Modification Date: 2026-05-27 @ 8:12 AM
Study NCT ID: NCT04493203
Status: COMPLETED
Last Update Posted: 2025-07-15
First Post: 2020-07-22
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Nivolumab Plus Axitinib in Patients With Anti-PD1 Refractory Advanced Melanoma
Sponsor: Yana Najjar
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Advanced Melanoma View
None Unresectable Melanoma View
Keywords: